Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype-Reference-Cited by-同舟云学术

Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Ghazi Alexandre¹,Le Corre Delphine¹,Pilati Camilla¹,Taieb Julien¹²,Aparicio Thomas³,Didelot Audrey¹,Dedhar Shoukat⁴,Mulot Claire¹,Le Malicot Karine⁵,Djouadi Fatima¹,de Reynies Aurélien⁶,Launay Jean-Marie⁷⁸,Laurent-Puig Pierre¹⁹,Mouillet-Richard Sophie¹^ORCID

Affiliation:

1. Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France

2. Department of Gastroenterology and GI Oncology, AP-HP, Hôpital Européen Georges Pompidou, Paris, France

3. Department of Gastroenterology and Digestive Oncology, AP-HP, Hôpital Saint-Louis, Université de Paris, Université Paris Diderot, Paris, France

4. Genetics Unit, Integrative Oncology, BC Cancer, Vancouver, Canada

5. Fédération Francophone de Cancérologie Digestive, Epicad Inserm, Université de Bourgogne et and Franche Comté, Dijon, France

6. Programme carte d'identité des tumeurs, Ligue Nationale Contre Le Cancer, Paris, France

7. AP-HP Service de Biochimie, INSERM U942 Lariboisière Hospital, Paris, France

8. Pharma Research Department, F. Hoffmann-La-Roche Ltd., Basel, Switzerland

9. Department of Biology, AP-HP, Hôpital Européen Georges Pompidou, Paris, France

Funder

Cancéropôle Ile de France

Association pour la recherche sur le cancer

Institut National de la Santé et de la Recherche Médicale

Fondation ARCAD

Labex Immuno-Oncology

siric carpem

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1940674

Reference39 articles.

1. Erratum: Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

2. The consensus molecular subtypes of colorectal cancer

3. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer

4. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

5. The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up;Oncogene;2024-08-15

2. Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer;Journal of Translational Medicine;2024-04-08

3. Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors;Frontiers in Immunology;2024-04-05

4. Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine;Clinical Cancer Research;2024-04-02

5. Small-molecule drugs of colorectal cancer: Current status and future directions;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01